Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06587568 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Mobile Chat Messaging for Alcohol Reduction in Patients With Chronic Liver Diseases

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date changed from estimate of Nov 30, 2025 to Sep 19, 2025
    • Study completion pushed from Dec 31, 2025 to Dec 31, 2026
    • Eligibility criteria expanded, about 8 words
  2. Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 100 to confirmed 106
    • Site details revised
    v3
  3. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Sep 17, 2024 to Oct 2, 2024
    v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this pilot randomized controlled trial is to evaluate the trial feasibility and acceptability of mobile chat messaging for reducing alcohol use among patients with chronic liver diseases. Specific objectives include: 1. To assess whether the eligibility criteria were too restrictive by estimating the eligibility rate 2. To assess how many eligible CLD patients accepted the invitation to participate in the trial 3. To assess the participant retention rate through 6 months after treatment initiation 4. To assess the intervention acceptability in terms of participants' engagement with and rating of the chat messaging intervention. 5. To assess the safety of the intervention 6. To estimate the intervention effect on alcohol use outcomes and liver functions 7. To synthesise data to inform the sample size calculation in the future definitive trial 8. To explore the participants' perception and experiences in the chat-based intervention
Trial Details
NCT Number NCT06587568
Lead Sponsor The University of Hong Kong
Collaborators: Health and Medical Research Fund
Conditions
(from sponsor)		 Chronic Liver Disease
Related terms Fibrosis, Hepatitis
Enrollment 106 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov